ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 132483 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 132483; 2) Community: the network communities that were significantly associated with the response to NSC 132483; 3) Molecule: the relationships between components within communities and NSC 132483; 4) MDR: the compounds that were significantly associated with the NSC 132483.

NSC Compound Enrichment Correlation
NSC 635591 9-N-(N'-bis-chloroethyl-N-1,4-diaminobutyl)2-methoxyacridine -dihydrochloride 0.00162803849483079 0.4384339
NSC 667909 Null 0.00162803849483079 0.040567101
NSC 670121 11-Hydroxy aclacinomycin A 0.00162803849483079 0.46355898
NSC 685285 Null 0.00162803849483079 0.34161792
NSC 686554 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- 0.00162803849483079 0.33719916
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.00162803849483079 0.30234068
NSC 718781 Erlotinib hydrochloride 0.00162803849483079 -0.16883517
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.00162803849483079 -0.23900494
NSC 726217 Combretastatin A4-analogue 0.00162803849483079 0.41668864
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.00162803849483079 -0.13213823
Total:176  Current:21    [First] [Prev] [Next] [Last]